Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,171
datasets available to search
ShareScore release 0.9.0
Dataset results
6,171 results for “mutant”
Efficacy of VIC Regimen in BRAF Mutant Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT04790448. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Pulsatile High-dose Furmonertinib in EGFR-mutant NSCLC With Leptomeningeal Metastasis
ClinicalTrials.gov study NCT07348965. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase 3 Trial of JMKX001899 Versus Docetaxel in Previously Treated Advanced or Metastatic KRAS G12C-Mutant NSCLC
ClinicalTrials.gov study NCT07242274. IPD Sharing: NO. Countries: 1. Publications: 0.
Aumolertinib in EGFR-Mutant Resected Stage IB-IIIA NSCLC (AERESA).
ClinicalTrials.gov study NCT06227897. IPD Sharing: YES. Countries: 1. Publications: 0.
High-dose Furmonertinib or Combined With Chemotherapy in EGFR-mutant Advanced NSCLC After Disease Progression on Third-generation EGFR-TKI
ClinicalTrials.gov study NCT06652048. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
ClinicalTrials.gov study NCT04181060. IPD Sharing: YES. Countries: 1. Publications: 0.
Adagrasib in Patients With KRASG12C-mutant NSCLC Who Are Elderly or Have Poor Performance Status
ClinicalTrials.gov study NCT05673187. IPD Sharing: YES. Countries: 6. Publications: 0.
Osimertinib, Cetuximab, and Tucatinib for the Treatment of EGFR-Mutant Stage IV or Recurrent Non-small Lung Cell Cancer
ClinicalTrials.gov study NCT06067776. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sacituzumab Tirumotecan Plus Third-Generation TKI With/Without Radiotherapy for EGFR-Mutant NSCLC Brain Metastases
ClinicalTrials.gov study NCT07343479. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex
ClinicalTrials.gov study NCT07027345. IPD Sharing: NO. Countries: 1. Publications: 0.
Osimertinib and Abemaciclib in EGFR Mutant Non-Small Cell Lung Cancer After Osimertinib Resistance
ClinicalTrials.gov study NCT04545710. IPD Sharing: NO. Countries: 1. Publications: 0.
Almonertinib Plus Chemotherapy as First-line Treatment in Patients With EGFR Concomitant Non-EGFR Driver Gene Mutant, Locally Advanced or Metastatic NSCLC
ClinicalTrials.gov study NCT04500704. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of ZG19018 in Patients With KRAS G12C Mutant Advanced Solid Tumors.
ClinicalTrials.gov study NCT06237400. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
ClinicalTrials.gov study NCT06607185. IPD Sharing: NO. Countries: 9. Publications: 0.
Vorasidenib in Combination With Temozolomide (TMZ) in IDH-mutant Glioma
ClinicalTrials.gov study NCT06478212. IPD Sharing: YES. Countries: 11. Publications: 0.
Befotertinib and Icotinib in Treatment-naive Patients With Advanced EGFR-Mutant Lung Cancer
ClinicalTrials.gov study NCT05007938. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Survival Outcome of EGFR-TKI in Uncommon EGFR Mutant Advanced NSCLC
ClinicalTrials.gov study NCT04324164. IPD Sharing: Not stated. Countries: 1. Publications: 0.
mFOLFOXIRI+Bev vs. mFOLFOX6+Bev for RAS Mutant Unresectable Colorectal Liver-limited Metastases
ClinicalTrials.gov study NCT04781270. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies
ClinicalTrials.gov study NCT03560882. IPD Sharing: NO. Countries: 1. Publications: 0.
Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm
ClinicalTrials.gov study NCT05025488. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.